Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome.
GPVI deficiency
TAFRO syndrome
anti-glycoprotein VI (GPVI) autoantibody
platelet dysfunction
recurrent cerebral hemorrhaging
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
1
7
2024
pubmed:
1
7
2024
entrez:
30
6
2024
Statut:
ppublish
Résumé
Thrombocytopenia, anasarca, fever, renal dysfunction, and organomegaly (TAFRO) syndrome is an inflammatory disorder with an unclear pathogenesis. We herein report a case of TAFRO syndrome in remission in a patient who experienced recurrent intracranial bleeding despite a normal platelet count and coagulation system. A further investigation suggested the presence of anti-glycoprotein VI (GPVI) autoantibodies in the plasma, which induced platelet dysfunction and bleeding tendency. No new bleeding or relapse of TAFRO syndrome occurred after immunosuppressive therapy was initiated. These findings may help elucidate the autoimmune pathogenesis of TAFRO syndrome.
Identifiants
pubmed: 38945933
doi: 10.2169/internalmedicine.2799-23
doi:
Substances chimiques
Autoantibodies
0
Platelet Membrane Glycoproteins
0
platelet membrane glycoprotein VI
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM